Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
about
dMM-PBSA: A New HADDOCK Scoring Function for Protein-Peptide DockingDe Novo Modular Development of a Foldameric Protein-Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach.Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapiesScreening-based approaches to identify small molecules that inhibit protein-protein interactions.Rewiring of the inferred protein interactome during blood development studied with the tool PPICompare.Exploring Non-obvious Hydrophobic Binding Pockets on Protein Surfaces: Increasing Affinities in Peptide-Protein Interactions.What is the future for fragment-based drug discovery?Structure-Guided Design of Peptides as Tools to Probe the Protein-Protein Interaction between Cullin-2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin LigasesThe impact of structural biology in medicine illustrated with four case studies.Flexibility is important for inhibition of the MDM2/p53 protein-protein interaction by cyclic β-hairpins.Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective.Polymerases of paramyxoviruses and pneumoviruses.Chiral Sulfoxide-Induced Single Turn Peptide α-Helicity.Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery.Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3aInhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound.Identification and characterization of a novel Sso7d scaffold-based binder against Notch1.Concise Synthesis of Tetrazole MacrocyclePeptide Macrocyclization Inspired by Non-Ribosomal Imine Natural Products.Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia.Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.Analysis of Borrelia burgdorferi Proteome and Protein-Protein Interactions.Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide.Comparative Proteomic Analysis of the Effect of Periplocoside P from Periploca sepium on Brush Border Membrane Vesicles in Midgut Epithelium of Mythimna separata Larvae.WD40 repeat domain proteins: a novel target class?The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.Finding a Silver Bullet in a Stack of Proteins.Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-The Genomic Landscape of the Fungus-Specific SWI/SNF Complex Subunit, Snf6, in Candida albicans.High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions.Toward a Novel Drug To Target the EGF-EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides.In silico ligand-based modeling of hBACE-1 inhibitors.Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.Complete protein-protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling.Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists.Directing evolution: the next revolution in drug discovery?Rational design and structure-activity relationship studies of quercetin-amino acid hybrids targeting the anti-apoptotic protein Bcl-xL.WNK Signaling Inhibitors as Potential Antihypertensive Drugs.Perspectives on the discovery of NOTCH2-specific inhibitors.
P2860
Q28596516-45A9ADD8-951B-4C40-81C0-C536CF3EDB49Q33562051-23875C12-914E-41D1-86D5-C25EBDA52184Q33767131-8C8B1D4A-5C12-443F-A176-0EFA55AEA259Q36244148-CB71EE2B-2C12-4359-AF37-C853786D9D0EQ36334812-CBF5A98A-C21A-4E93-B113-2410E2DF42E1Q36354076-5B2F5165-248A-4929-9969-D68DAFC06194Q38644516-91B2C0BF-B955-4DB7-B0D9-3DB3154CBD40Q38646896-F689E572-C17B-4BB7-996E-BAA9C3E40800Q38698199-B3B7FC63-AD19-4E85-BE4C-4323EF8C6827Q38812479-D1C23086-484A-4E9D-BDCE-C7FADBD94DF4Q38956084-5F837C39-5BEF-4CE0-BEAA-9F84339F088FQ39011481-CA213D3B-E3AA-4CED-9E07-05C44C73780BQ39116232-F99EED8D-3A5C-49F3-98BD-57918AC4419AQ39340519-43D9AC93-877C-4EA0-AB38-15493FA9796BQ41516139-52FE83E5-6B42-4227-A601-122B4C1C72E2Q41671042-9B63E847-ABDB-4E41-BF1F-6BF549FC7607Q41696862-0C5E7A7B-F17C-4891-8FEF-4BEEB55A22CEQ42267846-94D51A13-F201-4321-9A38-3146DEEFBB05Q42291656-14FD2F4C-41B5-4E02-9093-D05CBC99179DQ42365675-4DCB4AC8-D58E-480D-A592-BE6DF413A50DQ44233305-9E207A61-EB5A-43C1-B52F-C75FB06C2FB7Q45070104-7C29E530-007C-4853-8868-A31EC1245B8EQ47117237-635B9010-511D-4E21-B397-4B0D949BCE56Q47260990-8C0B3612-5E36-44ED-AF07-BD13BA992417Q47291150-5DF4958E-2F24-40C2-B28B-6D622B2B0528Q47302603-2E5096B2-5EB8-45F1-BB1B-140C3A5AD97BQ47302924-08931B29-E568-43B0-B9F3-AD95781C4DF5Q47324161-47A844EA-5116-4BEA-8F6D-4DB2C7893E06Q47388204-11BB38CF-47C4-4081-8970-B7F7A4C8CAB6Q47431069-969AAA97-2CBD-4AF6-9AB9-DBCE766883ECQ47438448-0DEE8810-90C0-4CAC-B8DB-2938C72D98A6Q47565168-022A5591-CF80-4D89-B449-DCB45492A9DFQ47661011-9D6365BE-1F5F-4AA1-9295-AA1DE12B3A29Q47661976-23EEA058-3A96-4398-81B8-035767EFBD93Q47677852-8FA20D95-3BDE-4073-AC52-17ED0DB2C9EAQ47726693-4D6410AC-1308-4A96-ABE0-CC1272A379FAQ47764181-29BFAFE9-E526-4055-9B1F-E37D755FF01EQ47810232-3B16605F-6433-4BDB-9BA5-687C33F23FF1Q47841545-36D7D549-63FA-4FD9-8F71-19C25AB0CACFQ48113221-7BF55E5D-8148-48C3-B461-286E7568519E
P2860
Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Small molecules, big targets: ...... protein interaction challenge.
@ast
Small molecules, big targets: ...... protein interaction challenge.
@en
type
label
Small molecules, big targets: ...... protein interaction challenge.
@ast
Small molecules, big targets: ...... protein interaction challenge.
@en
prefLabel
Small molecules, big targets: ...... protein interaction challenge.
@ast
Small molecules, big targets: ...... protein interaction challenge.
@en
P2093
P2860
P356
P1476
Small molecules, big targets: ...... protein interaction challenge.
@en
P2093
Andrew R Bayly
Chris Abell
Duncan E Scott
P2860
P2888
P304
P356
10.1038/NRD.2016.29
P577
2016-04-11T00:00:00Z
P6179
1031490588